{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:28:27Z","timestamp":1793978907013,"version":"4.8.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2025LSW009"],"award-info":[{"award-number":["ZR2025LSW009"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2025LMB029"],"award-info":[{"award-number":["ZR2025LMB029"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2023LZY008"],"award-info":[{"award-number":["ZR2023LZY008"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2024LMB016"],"award-info":[{"award-number":["ZR2024LMB016"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22507064"],"award-info":[{"award-number":["22507064"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20230251"],"award-info":[{"award-number":["BK20230251"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119220","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:06:37Z","timestamp":1786374397000},"page":"119220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and antitumor evaluation of celastrol derivatives targeting PRDX3"],"prefix":"10.1016","volume":"319","author":[{"given":"Yuchen","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanshuang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaili","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haisheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4775-0143","authenticated-orcid":false,"given":"Chuanfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2026.119220_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41392-026-02583-x","article-title":"Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications","volume":"11","author":"Akter","year":"2026","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119220_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.cstres.2025.100108","article-title":"Reactive oxygen species in cancer: mechanistic insights and therapeutic innovations","volume":"30","author":"Ma","year":"2025","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.ejmech.2026.119220_bib3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2017.01.004","article-title":"Reactive oxygen species and cancer paradox: to promote or to suppress?","volume":"104","author":"Galadari","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2026.119220_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev-cancerbio-041916-065808","article-title":"The two faces of reactive oxygen species in cancer","volume":"1","author":"Reczek","year":"2017","journal-title":"Ann. Rev. Cancer Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119220_bib5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13046-018-0909-x","article-title":"The role of cellular reactive oxygen species in cancer chemotherapy","volume":"37","author":"Yang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119220_bib6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/j.seminoncol.2021.05.002","article-title":"Implications of reactive oxygen species on cancer formation and its treatment","volume":"48","author":"Shah","year":"2021","journal-title":"Semin. Oncol."},{"issue":"22","key":"10.1016\/j.ejmech.2026.119220_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212387","article-title":"Oxidative stress and cancer therapy: controlling cancer cells using reactive oxygen species","volume":"25","author":"Ju","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.ejmech.2026.119220_bib8","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.3390\/ijms20184407","article-title":"Interplay between mitochondrial peroxiredoxins and ROS in cancer development and progression","volume":"20","author":"Ismail","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119220_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13046-018-0948-3","article-title":"Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs\/ROS\/Trx1 signalling pathway","volume":"37","author":"Jin","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119220_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3892\/etm.2021.9870","article-title":"MicroRNA-383 promotes reactive oxygen species-induced autophagy via downregulating peroxiredoxin 3 in human glioma U87 cells","volume":"21","author":"Xu","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejmech.2026.119220_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2024.102494","article-title":"Antioxidant PRDX3 gene therapy protects brain cells and prevents neurodegeneration in an animal model of Parkinson's disease","volume":"110","author":"Villa-Cedillo","year":"2025","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ejmech.2026.119220_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114896","article-title":"New insights into the roles of peroxiredoxins in cancer","volume":"164","author":"Liu","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119220_bib13","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/brain\/awab071","article-title":"Biallelic loss-of-function variations in PRDX3 cause cerebellar ataxia","volume":"144","author":"Rebelo","year":"2021","journal-title":"Brain"},{"issue":"15","key":"10.1016\/j.ejmech.2026.119220_bib14","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.7150\/ijms.118912","article-title":"PRDX3 promotes lymph node metastasis in cervical cancer by activating NF-\u03baB signaling pathway and anoikis resistance","volume":"22","author":"Wen","year":"2025","journal-title":"Int. J. Med. Sci."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119220_bib15","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.7150\/ijbs.114510","article-title":"SIRT4-Mediated deacetylation of PRDX3 attenuates liver ischemia reperfusion injury by suppressing ferroptosis","volume":"21","author":"Yu","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejmech.2026.119220_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101343","article-title":"SIRT3-mediated deacetylation of PRDX3 alleviates mitochondrial oxidative damage and apoptosis induced by intestinal ischemia\/reperfusion injury","volume":"28","author":"Wang","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2026.119220_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102297","article-title":"Icariin alleviates uveitis by targeting peroxiredoxin 3 to modulate retinal microglia M1\/M2 phenotypic polarization","volume":"52","author":"Wang","year":"2022","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119220_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1871520618666180108100211","article-title":"The clinical and experimental research on the treatment of endometriosis with thiostrepton","volume":"19","author":"Jin","year":"2019","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119220_bib19","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41419-022-05082-3","article-title":"Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3\/GPX4 signalling","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"20","key":"10.1016\/j.ejmech.2026.119220_bib20","doi-asserted-by":"crossref","first-page":"17161","DOI":"10.1021\/jacs.5c02720","article-title":"Catalyst-controlled site-selective and epimer-selective hydrogenations of thiostrepton","volume":"147","author":"Peterson","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119220_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000462","article-title":"Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy","volume":"8","author":"Wang","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"17","key":"10.1016\/j.ejmech.2026.119220_bib22","doi-asserted-by":"crossref","first-page":"9717","DOI":"10.3390\/ijms25179717","article-title":"Thiostrepton as a potential therapeutic agent for hepatocellular carcinoma","volume":"25","author":"Su","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119220_bib23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s10637-019-00779-3","article-title":"A preclinical evaluation of thiostrepton, a natural antibiotic, in nasopharyngeal carcinoma","volume":"38","author":"Hsu","year":"2020","journal-title":"Invest. N. Drugs"},{"issue":"44","key":"10.1016\/j.ejmech.2026.119220_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ady4492","article-title":"Mechanism-based peroxiredoxin 3 inhibitors exploit a covalent warhead for cancer therapy","volume":"11","author":"Nelson","year":"2025","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119220_bib25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1248\/cpb.c18-00767","article-title":"Potential anticancer activity of auranofin","volume":"67","author":"Onodera","year":"2019","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"issue":"18","key":"10.1016\/j.ejmech.2026.119220_bib26","doi-asserted-by":"crossref","first-page":"15719","DOI":"10.1021\/jacs.5c03186","article-title":"Subcellular photocatalysis enables tumor-targeted inhibition of thioredoxin reductase I by Organogold(I) complexes","volume":"147","author":"Liu","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119220_bib27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/vco.13005","article-title":"Auranofin suppresses the growth of canine mammary tumour cells and induces apoptosis via the PI3K\/AKT pathway","volume":"22","author":"Lin","year":"2024","journal-title":"Vet. Comp. Oncol."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119220_bib28","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.apsb.2021.12.007","article-title":"Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1","volume":"12","author":"Luo","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119220_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41392-022-01231-4","article-title":"Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1","volume":"8","author":"Xu","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2026.119220_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115656","article-title":"Development of novel celastrol-ligustrazine hybrids as potent peroxiredoxin 1 inhibitors against lung cancer","volume":"259","author":"Bai","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"10\u201312","key":"10.1016\/j.ejmech.2026.119220_bib31","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/10715762.2025.2592016","article-title":"Peroxiredoxins: regulatory roles and potential clinical significances in breast cancer","volume":"59","author":"Qi","year":"2025","journal-title":"Free Radic. Res."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119220_bib32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12967-021-02792-8","article-title":"Expression and prognostic roles of PRDXs gene family in hepatocellular carcinoma","volume":"19","author":"Xu","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.119220_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1713670","article-title":"Clinical value and molecular role of PRDXs family in prostate cancer","volume":"15","author":"Yao","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2026.119220_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115758","article-title":"Carnosol alleviates nonalcoholic fatty liver disease by inhibiting mitochondrial dysfunction and apoptosis through targeting of PRDX3","volume":"432","author":"Geng","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119220_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2026.112502","article-title":"PPT1 regulates mitochondrial redox by depalmitoylating PRDX3","volume":"143","author":"Zhu","year":"2026","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2026.119220_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103436","article-title":"Human mitochondrial peroxiredoxin Prdx3 is dually localized in the intermembrane space and matrix subcompartments","volume":"78","author":"Gomes","year":"2024","journal-title":"Redox Biol."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119220_bib37","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1073\/pnas.102523299","article-title":"The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation","volume":"99","author":"Wonsey","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2026.119220_bib38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuint.2018.02.004","article-title":"Peroxiredoxin-3 attenuates traumatic neuronal injury through preservation of mitochondrial function","volume":"114","author":"Hu","year":"2018","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119220_bib39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40199-024-00504-3","article-title":"Dexmedetomidine alleviates hypoxia\/reoxygenation-induced mitochondrial dysfunction in cardiomyocytes via activation of Sirt3\/Prdx3 pathway","volume":"32","author":"Tan","year":"2024","journal-title":"Daru"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119220_bib40","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4149\/neo_2022_220304N241","article-title":"Silencing of B7-H4 induces intracellular oxidative stress and inhibits cell viability of breast cancer cells via downregulating PRDX3","volume":"69","author":"Chen","year":"2022","journal-title":"Neoplasma"},{"key":"10.1016\/j.ejmech.2026.119220_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2025.102073","article-title":"Targeted mitochondrial metabolism for anti-tumor therapy","volume":"85","author":"Yan","year":"2025","journal-title":"Mitochondrion"},{"issue":"10","key":"10.1016\/j.ejmech.2026.119220_bib42","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.1021\/acs.jmedchem.3c02018","article-title":"Antitumor activity and mechanistic insights of a mitochondria-targeting Cu(I) complex","volume":"67","author":"Xu","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119220_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105271","article-title":"Design, synthesis and antitumor activities of thiazole-containing mitochondrial targeting agents","volume":"115","author":"Zhang","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119220_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.118755","article-title":"Dual functionalization of steviol enables mitochondrial targeting and redox modulation in antitumor therapy","volume":"309","author":"Li","year":"2026","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119220_bib45","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1158\/1078-0432.CCR-21-0833","article-title":"Antitumor activity of a mitochondrial-targeted HSP90 inhibitor in gliomas","volume":"28","author":"Wei","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119220_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116466","article-title":"Antitumor and toxicity study of mitochondria-targeted celastrol derivatives using triphenylphosphine (TPP+) as a carrier","volume":"50","author":"Song","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119220_bib47","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2174\/1567201819666220525092527","article-title":"Delocalized lipophilic cation triphenyl phosphonium: promising molecule for mitochondria targeting","volume":"20","author":"Pawar","year":"2023","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejmech.2026.119220_bib48","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.redox.2017.09.020","article-title":"A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: therapeutic targeting of tumor mitochondria with lipophilic cationic compounds","volume":"14","author":"Kalyanaraman","year":"2018","journal-title":"Redox Biol."},{"issue":"15","key":"10.1016\/j.ejmech.2026.119220_bib49","doi-asserted-by":"crossref","first-page":"10043","DOI":"10.1021\/acs.chemrev.7b00042","article-title":"Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications","volume":"117","author":"Zielonka","year":"2017","journal-title":"Chem. Rev."},{"issue":"47","key":"10.1016\/j.ejmech.2026.119220_bib50","doi-asserted-by":"crossref","first-page":"19684","DOI":"10.1021\/jacs.1c07099","article-title":"Mitoquinone inactivates mitochondrial chaperone TRAP1 by blocking the client binding site","volume":"143","author":"Yoon","year":"2021","journal-title":"J. Am. Chem. Soc."},{"issue":"96","key":"10.1016\/j.ejmech.2026.119220_bib51","doi-asserted-by":"crossref","first-page":"18937","DOI":"10.1039\/D5CC05709D","article-title":"Triphenylphosphonium-based mitochondrial targeting in cancer therapy: mechanisms, progress, and perspectives","volume":"61","author":"Yang","year":"2025","journal-title":"Chem. Commun."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:05:40Z","timestamp":1793977540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426006653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":51,"alternative-id":["S0223523426006653"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119220","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and antitumor evaluation of celastrol derivatives targeting PRDX3","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119220","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119220"}}